There is no clinically validated human dose you can look up here, because for this compound one does not exist in the way regulated drugs have. We report what research and regulators actually say, and nothing more.
What it is
Ipamorelin is a small peptide that mimics ghrelin to stimulate growth-hormone release, valued in the community for being relatively selective (less effect on cortisol or prolactin than older GHRPs). It is commonly stacked with CJC-1295.
The evidence, stated plainly
Human data is limited; it reliably triggers GH release in short studies, but there are no large controlled trials establishing benefit or safety for the physique and anti-aging uses it is marketed for. Not approved; prohibited in sport.
Evidence is largely preclinical (animal/in-vitro). We label evidence by its strongest honest tier, never by a vendor’s enthusiasm.
Half-life & timing
Its half-life is on the order of a couple of hours, which is why community protocols dose it more than once daily. Human pharmacology data remains thin.
Regulatory status
Not FDA-approved. Sold as a research chemical and prohibited in sport. No established human dosing standard exists.
Storage & handling
Standard peptide handling: cold storage of lyophilized powder, bacteriostatic water for reconstitution, refrigerated solution used within weeks, gentle swirling only.
Whatever dose a protocol or provider gave you, converting it to syringe units is where errors turn into 10× mistakes. Our calculator does only that conversion — it never invents the dose.
Open the reconstitution calculatorThe honest bottom line
Ipamorelin is one of the "cleaner" GH secretagogues by reputation, but reputation is not a trial. It raises GH short-term; long-term human safety and benefit for body composition are simply not established.
Sources
- Short human GH-response studies of ipamorelin.
- Regulatory/sport status references.
- Peptide storage/reconstitution protocols.
Sourcing reflects literature available at publication and may change. See How We Rate Evidence.